Johannes Czernin, M.D.
Positions & Affiliations:
Professor and Vice Chair, Departmennt of Molecular and Medical Pharmacology
Chief, Ahmansonn Translational Theranostics Division
Director, JCCC Cancer Molecular Imaging Program, Nanotechnology and Theranostics Program
As the Chief of the Ahmanson Translational Theranostics Division part of the UCLA Department of Molecular and Medical Pharmacology, Dr. Czernin has over 25 years of experience in preclinical molecular imaging and molecular radiotherapy.
Dr. Johannes Czernin received his MD degree from the University of Vienna in 1983. He was board certified in Internal Medicine in AUSTRIA in 1989 and in Nuclear Medicine in 1996 in the USA. He was named Director of Nuclear Medicine at the David Geffen School of Medicine at UCLA in 1996 and currently serves as the Chief of the Ahmanson Translational Theranostics Division at UCLA. The Division includes the Nuclear Medicine Clinic, a clinical imaging research program, a drug and probe development program with a strong underpinning in tumor biology, and a preclinical imaging center. The Division collaborates within the department of molecular and medical pharmacology and across several other departments including medicine, surgery, radiology, neurology, pathology and others. Dr. Czernin is currently Editor-in-Chief of the Journal of Nuclear Medicine and is a past president of the Academy of Molecular Imaging. He has published more than 280 peer-reviewed research papers.